BIH @ Berlin Science Week | Various Offers
As in previous years, the BIH was also part of this year's Berlin Science Week, which took place from 1 to 10 November 2021.
Berlin Science Week provides international scientists and science driven organisations with a stage to share insights into current topics, discuss grand challenges and envision the future together. Throughout ten festival days and beyond, it fosters debates and knowledge exchange in an open and interdisciplinary spirit.
Here you can find a review of our events during Berlin Science Week 2021:
The relevance of Aristotle for modern biomedicine and the problem of "translation" between basic scientific research and clinical application will be presented in two lectures with subsequent discussion by Philip van der Eijk (Humboldt-Universität zu Berlin, academician) and Daniel Strech (Berlin Institute of Health at Charité).
Welcome and Moderation
- Christoph Markschies (Akademiepräsident)
Lecture [in German]– "Aristoteles, Biomedizin und das medizinische Handeln"
- Philip van der Eijk (Akademie Member, Humboldt-Universität zu Berlin)
Lecture [in German]– "Erkenntnistheoretische und ethische Herausforderungen der gegenwärtigen translationalen Forschung"
- Daniel Strech (Berlin Institute of Health at Charité)
Panel Discussion and Presentation of the Anthology [in German]
„Was ist Gesundheit? Interdisziplinäre Perspektiven aus Medizin, Geschichte und Kultur“
- Philip van der Eijk, Detlev Ganten and Roman Marek
The Covid-outbreak in the end of 2019 took the world by surprise. After almost two years into the pandemic, science has made great progress and politicians have made valuable experiences concerning the management of the global crisis. But can we use the knowledge we acquired if a similar scenario strikes again?
The great success of our event-series “Future Medicine Science Match”, hosted by Berlin’s leading Newspaper Der Tagesspiegel and the Berlin Institute of Health at Charité (BIH) in the past years inspired us to hold it once again as Online Event in a Round Table-format.
The following questions were discussed:
Have we already learned enough about the pandemic?
Can the learnings regarding effective therapies and preventive measures be applied for another pandemic?
What are the side effects of the pandemic on the health system (e.g. delay of diagnosis and therapies of other diseases like cancer, cardiovascular diseases or chronical illnesses)?
Are science and politics prepared for the next pandemic?
Among others with Prof. Christof von Kalle (BIH/Charité), Prof. Leif Erik Sander (Charité), Prof. Veronika von Messling (Federal Ministry of Education and Research) and Dr. Oliver Morgan (WHO).
The Round Table was recorded.
What needs to be done?
Rapidly evolving digital technology and data science have started to transform our lifestyles. In the context of our health, they have been partially successful in promoting our biological health, so that we might live on to beyond 100 years old. Advanced technologies have enabled us to predict disease onsets early, meaning that there is room to take action and modify lifestyles to postpone or escape from diseases on an individual basis.
But are we happy with what we have achieved already? Definitely not!
We would like to have the technologies as unobtrusive as possible, and to have them not interrupting our lives. We would like to have digital health technologies to support our lives, thus staying not only clinically healthy but also vital and actively participating in society. In the seminar future perspectives of how digital technology can improve our lives were discussed.
Among others with Prof. Sylvia Thun (Director Core Facility Digital Medicine and Interoperability at the Berlin Institute of Health at Charité).
Public Discussion via livestream and on-site at the Berlin Science Week Campus.
Panel discussion on the subject “Cardiovascular Health in Times COVID-19”, organized by Springer Nature, in collaboration with the Max-Delbrück-Centrum für Molekulare Medizin and the Berlin Institute of Health at Charité (BIH).
COVID-19, caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic that has affected the lives of the entire human population. The speakers of the panel, composed of Berlin-based renowned experts in basic, translational and clinical science focused on cardiovascular disease and immunology, discuss the following three key aspects:
- How pre-existing cardiovascular condition is associated with worse outcomes and increased risk of death in patients with COVID-19,
- how COVID-19 itself can induce cardiovascular disease, such as venous thromboembolism, high blood pressure, acute coronary syndrome, myocardial injury,
- and arrhythmia, and how we can minimize all these risks by vaccination.
- Prof Holger Gerhardt, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute of Health (BIH) at Charité and DZHK (German Center for Cardiovascular Research) Partner Site Berlin
- Prof Michael Potente, BIH and MDC
- Prof Leif Erik Sander, Charité – Universitätsmedizin Berlin (Dept. of Infectious Diseases and Respiratory Medicine)
- Prof Birgit Sawitzki, BIH and Charité – Universitätsmedizin Berlin (Institute of Medical Immunology)
- Dr. Emanuel Wyler, MDC
Moderation: Dr. Vesna Todorovic, Chief Editor, Nature Cardiovascular Research
The panel discussion was recorded.
Can stem cell therapies help with the major common diseases? How far has research progressed and how does research become health?
At the Berlin Institute of Health at the Charité, the BIH, research on and with cells plays a major role: Scientists investigate at the single cell level which cells it is that are affected by the coronavirus, search for cancer stem cells that are the root of the tumor, or treat organ recipients with cells from their own immune system to prevent rejection. Can stem cell therapies help with major common diseases? Unproven therapies entice with hasty solutions - how far is research and what could medicine of the future look like?
BIH and the German Stem Cell Network offered a joint info booth on this subject at the Berlin Science Week Campus at the Museum of Natural History. Scientists were there on hand to talk about their research. Films, games and information material invited everyone to talk about cell research and future cell therapies. About 200 visitors stopped by, learnt the secrets of stem cells and took part in a big cell quiz to understand the motto of the BIH: From research to health!
Meet-Up with our scientists
Dr. Michael Schmück-Henneresse (BIH Center für Regenerative Therapien (BCRT) , Berlin Center for Advanced Therapies (BeCAT), Charité – Universitätsmedizin Berlin)
With Immune Cells Against Diseases
Dr. med. Verena Schöwel und Christian Stadelmann (M. Sc.)
(Hochschulambulanz für Muskelkrankheiten und Muscle Research Unit, Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin und Max Delbrück Centrum für Molekulare Medizin)
Muscle Stem Cells for Therapy
Dr. Daniel Besser (Geschäftsführer German Stem Cell Network GSCN)
False Hope - Unproven stem cell therapies lure with hasty solutions. How far along is research?
Prof. Christian Conrad (Intelligent Imaging am Digital Health Center von BIH und Charité –Universitätsmedizin Berlin)
Organoids From Cancer Stem Cells
What the view of individual cells brings to medicine: a teacher training course.
For organs or living organisms to function, countless cells must communicate with each other, develop and specialize. To do this, they repeatedly retrieve different information from the genome. With new omics technologies such as single-cell analysis, researchers can precisely observe on a large scale how cells and their interaction change in the course of diseases. Thanks to this precision, they can even see rare cell types such as stem cells - which are of therapeutic interest. If you want to diagnose diseases earlier and treat them with precision, you have to look at the cellular level.
Public training course with Patrick Maschmeyer and Leif Ludwig (MDC | BIH | Charité)
From 1 to 10 November 2021, researchers gathered in Berlin to discuss current issues - with each other and with the public. The Max Delbrück Center for Molecular Medicine (MDC) was contributing to exciting events, online and on site.
From November 1 to 10, Berlin was all about research and innovation. During Berlin Science Week, scientists provided insights into current research and exchanged ideas with the Berlin public about the challenges of our time at over 200 events. Scientists from Charité - Universitätsmedizin Berlin held discussions on panels, offered workshops and presented their research in the fields of medicine and life sciences.